Sarpogrelate
Sarpogrelate (MCI-9042) is a new, specific orally active 5-HT2 receptor antagonist, Sarpogrelate increases platelet aggregation and has hemostasis effect, and can be used for the research of Buerger’s disease[1].
Product Specifications
CAS Number
125926-17-2
Product Name Alternative
MCI-9042 (free acid)
UNSPSC
12352005
Target
5-HT Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/sarpogrelate.html
Solubility
10 mM in DMSO
Smiles
COC1=CC=CC(CCC2=CC=CC=C2OCC(CN(C)C)OC(CCC(O)=O)=O)=C1
Molecular Formula
C24H31NO6
Molecular Weight
429.51
References & Citations
[1]A Rydzewski, et al. The effect of a 5HT2 receptor antagonist sarpogrelate (MCI-9042) treatment on platelet function in Buerger's disease. Thromb Res. 1996 Dec 15;84 (6) :445-52.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
α-1 microglobulin
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
